NutriBand (NTRB) Cash from Operations (2016 - 2026)
NutriBand (NTRB) posted Cash from Operations of 563104.0 for Q2 2026, up 23.06% sequentially from 731830.0 in Q1 2026, and up 57.88% YoY from 356660.99 in Q2 2025.
NutriBand (NTRB) Cash from Operations (2016 - 2026) Analysis & Trends
NutriBand has reported Cash from Operations for 11 years, with the latest figure at 563104.0 in Q2 2026.
- Quarterly Cash from Operations rose 57.88% year-over-year to 563104.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 4360762.0 (up 14.99% YoY) and the FY2026 annual result came in at 5134630.0, down 10.98% from the prior year.
- Cash from Operations improved to 563104.0 in Q2 2026 per NTRB's latest filing, from 731830.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 520443.0 in Q4 2022 and troughed at 1752487.0 in Q4 2025.
- A 5-year average of 1003968.83 and a median of 951814.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2026: Cash from Operations tumbled 1382.25% in 2022, then jumped 57.88% in 2026.
- Over 5 years, Cash from Operations stood at 520443.0 in 2022, then plunged by 104.49% to 1064270.0 in 2023, then grew by 5.13% to 1009647.0 in 2024, then slumped by 73.57% to 1752487.0 in 2025, then soared by 67.87% to 563104.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 563104.0, 731830.0, and 1752487.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 326.72 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -88.83 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 728.46 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.27 Mn |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 | -563,104.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -563,104.00 |
| Apr 30, 2026 | -563,104.00 |
| Jan 31, 2026 | -731,830.00 |
| Jan 31, 2026 | -731,830.00 |
| Oct 31, 2025 | -1.75 Mn |
| Oct 31, 2025 | -1.75 Mn |
| Jul 31, 2025 | -1.31 Mn |
| Jul 31, 2025 | -1.31 Mn |
| Apr 30, 2025 | -1.34 Mn |
| Apr 30, 2025 | -1.34 Mn |
| Jan 31, 2025 | -1.24 Mn |
| Jan 31, 2025 | -1.24 Mn |
| Oct 31, 2024 | -1.01 Mn |
| Oct 31, 2024 | -1.01 Mn |
| Jul 31, 2024 | -1.54 Mn |
| Jul 31, 2024 | -1.54 Mn |
| Apr 30, 2024 | -833,926.00 |
| Apr 30, 2024 | -833,926.00 |
| Jan 31, 2024 | -718,240.00 |
| Jan 31, 2024 | -718,240.00 |